( February 5, 2026, 1:45 PM EST) -- NEW YORK — A New York federal judge on Feb. 4 granted a motion to seal by pharmaceutical companies in a relator’s federal False Claims Act (FCA) suit against the companies and Pfizer Inc. over allegedly manufacturing and distributing a drug that fails to meet specifications of the U.S. Food and Drug Administration, finding that the documents sought to be sealed contain research and development information that, if disclosed, could subject one of the companies to “competitive harm.”...